Cargando…
Design of a framework for the deployment of collaborative independent rare disease-centric registries: Gaucher disease registry model
Orphan drug clinical trials often are adversely affected by a lack of high quality treatment efficacy data that can be reliably compared across large patient cohorts derived from multiple governmental and country jurisdictions. It is critical that these patient data be captured with limited corporat...
Autores principales: | Bellgard, Matthew I., Napier, Kathryn R., Bittles, Alan H., Szer, Jeffrey, Fletcher, Sue, Zeps, Nikolajs, Hunter, Adam A., Goldblatt, Jack |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academic Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5729019/ https://www.ncbi.nlm.nih.gov/pubmed/28190666 http://dx.doi.org/10.1016/j.bcmd.2017.01.013 |
Ejemplares similares
-
Does the registry speak your language? A case study of the Global Angelman Syndrome Registry
por: Tones, Megan, et al.
Publicado: (2023) -
A web-based, patient driven registry for Angelman syndrome: the global Angelman syndrome registry
por: Napier, Kathryn R., et al.
Publicado: (2017) -
Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry
por: Nguyen, Yann, et al.
Publicado: (2020) -
Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry
por: Rosenbloom, Barry E., et al.
Publicado: (2022) -
Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry
por: Mistry, Pramod K., et al.
Publicado: (2017)